News
Also: Valo Health closes $300 million for machine learning drug discovery; Blue Note Therapeutics supports its in-development prescription DTx with $26.25 million.
The company is launching the Fitbit Ace 3 for $79.99.
The digital MSK company is looking to bundle the non-invasive, non-addictive pain reduction device alongside the rest of its employer-focused offerings.
The study looks at menstruation symptoms and features from over 10,000 participants.
The joint venture will enable the companies to collaborate through a virtual platform and physical base in Paris.
According to Business Insider, the pair made a $70 million licensing deal.
Also: Mantra Health appoints medical director; Deep 6 AI creates VP of life sciences role.
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
Study finds nasal spray delivery offers "many benefits" over traditional approaches to vaccine administration.